Effect of deflazacort on bone mineral density in renal transplant recipients.
Kim
M S
MS
Department of Surgery, Yonsei University Wonju College of Medicine, Ilsan-dong, Wonju, Korea.
Kim
Y S
YS
Lim
S K
SK
Kim
S I
SI
Moon
J I
JI
Park
K
K
D000596:Amino Acids / Q000652:urine; D015415:Biomarkers / Q000097:blood / Q000652:urine; D015519:Bone Density / Q000187:drug effects* / Q000502:physiology; D006085:Graft Survival; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000502:physiology*; D015675:Osteocalcin / Q000097:blood / Q000652:urine; D010024:Osteoporosis / Q000517:prevention & control; D011183:Postoperative Complications / Q000517:prevention & control; D011241:Prednisone / Q000627:therapeutic use*; D011282:Pregnenediones / Q000627:therapeutic use*
D000596:Amino Acids; D015415:Biomarkers; D007166:Immunosuppressive Agents; D011282:Pregnenediones; D015675:Osteocalcin; C036020:deoxypyridinoline; C021988:deflazacort; D011241:Prednisone